⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

SpecGx, LLC: Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. C

DrugsSource: FDA (drug) · Date: 2026-01-14

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
SpecGx, LLC
Product
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Reason / hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide
Recall initiated
2025-12-16
Code info
Lot: 0522J23493, expires: 03/2027.
Product quantity
74,544 bottles
Voluntary mandated
Voluntary: Firm initiated
City
Webster Groves
State
MO
Country
United States
Event id
98136
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.